The quantum computing trade has shifted from a speculative bet to an identifiable, investable theme, and the three exchange-traded funds that best capture it each take a different angle on the same transition. Defiance Quantum ETF (NYSEARCA:QTUM) holds a pure-play roster of qubit makers and quantum-adjacent semiconductor companies. ARK Autonomous Technology & Robotics ETF (NYSEARCA:ARKQ) layers active management over an autonomous-tech mandate that touches the same compute build-out. Global X Robotics & Artificial Intelligence ETF (NASDAQ:BOTZ | BOTZ Price Prediction) provides picks-and-shovels exposure through industrial automation and AI hardware.
The catalysts are concrete, and on May 21, 2026, the Department of Commerce announced about $2 billion in CHIPS Act letters of intent to nine quantum companies, including $100 million each for D-Wave, Rigetti, Quantinuum, PsiQuantum, Atom Computing, and Infleqtion. That federal capital builds on IBM’s error-correction milestones and Google’s Willow chip benchmarks, which have shifted the conversation from “will quantum work” to “which modality scales first.” Performance has tracked the narrative: QTUM is up 45% year-to-date and 86% over the last 12 months.
QTUM: The Most Direct Bet on Qubit Commercialization
QTUM is the only ETF on this list designed around the quantum thesis itself. The fund tracks the BlueStar Quantum Computing and Machine Learning Index, holding the listed pure-plays (IonQ, Rigetti, D-Wave, Quantum Computing Inc.) alongside larger platform owners that house quantum research divisions, including IBM, Alphabet, and Honeywell. That basket is what gives the fund its claim to being the only quantum-specific ETF, because the index methodology explicitly screens for companies whose business activities tie back to quantum computing or machine learning, rather than letting a generic tech sleeve dominate the weighting.
The expense ratio sits at 0.40%, competitive for a thematic fund this narrow. The portfolio is roughly equal-weighted, which matters more than it sounds: a market-cap weighted basket would be dominated by IBM, Alphabet, and a few semiconductor giants, diluting the pure-play exposure to IonQ and Rigetti that most investors want. Equal weighting keeps the small qubit companies meaningful contributors to returns.
The tradeoff for investors is volatility. When IonQ or Rigetti rise on a CHIPS funding headline, QTUM captures it directly. When those names are reduced by 30% due to a missed milestone, the fund feels it sharply. The recent move tells that story, with QTUM up roughly 23% over the past month.
ARKQ: The Active Overlay on Compute and Autonomy
ARKQ takes a different path to similar end markets. The fund is actively managed with a mandate to invest at least 80% of assets in autonomous technology and robotics companies, giving portfolio managers latitude to lean into quantum-adjacent names without being bound by an index. Net assets stand at $2.1 billion, and the expense ratio is 0.75%, the cost of active management in a thematic wrapper.
The top holdings show how that mandate translates into compute exposure. Tesla anchors the fund at about 10%, followed by Teradyne at around 7% and Kratos Defense at around 5%, with Advanced Micro Devices and Palantir each at around 8% and 3%, respectively. The semiconductor and testing names matter for the quantum thesis because qubit systems need classical control electronics, cryogenic test infrastructure, and AI orchestration software to operate. Teradyne builds the test equipment, AMD provides the classical compute layer, and Palantir handles the data workflows that quantum simulations will eventually plug into.
ARKQ has returned 25% year-to-date and 76% over the past year. It’s worth noting that 10 positions account for more than half of the fund, and a drawdown in Tesla moves the whole portfolio. Investors who want active conviction with quantum-adjacent positioning, rather than direct qubit exposure, find that here.
BOTZ: The Picks-and-Shovels Inclusion
BOTZ takes the broadest approach of the three. The fund manages roughly $3.44 billion in net assets, making it the largest of the three by a wide margin, and concentrates in industrial robotics, machine vision, and AI compute hardware. The case for including it in a quantum-themed portfolio rests on a single mechanism: every quantum system shipped requires a stack of classical infrastructure underneath it, and that stack is exactly what BOTZ owns.
Keyence sits at roughly 9% of net assets, ABB at about 9%, FANUC near 9%, and NVIDIA around 8%. NVIDIA is the obvious AI compute exposure, but the industrial automation names matter because the Japanese and European robotics leaders supply the precision manufacturing equipment that fabricates qubit chips, photonic packages, and cryogenic enclosures. The fund holds 51 positions across roughly a dozen automation verticals, with heavy weighting toward Japan.
Year to date, BOTZ is up 11%, with a one-year return of 30%. The lag versus QTUM reflects the trade-off: less direct quantum upside, but also less drawdown risk when a single-qubit company misses a milestone. The five-year return of 19% is a reminder that broad automation exposure does not always compound as much as pure thematic plays do during a hype cycle.
How to Choose Between Them
QTUM is the right vehicle for someone who wants direct exposure to the qubit commercialization trade and accepts that the equal-weight methodology will deliver both the upside and the volatility of the small pure-plays. CHIPS funding announcements and milestones from IBM and Google are the kinds of catalysts that move this fund the most.
ARKQ fits the investor who wants active management and is comfortable with a concentrated, conviction-driven portfolio that touches quantum themes through the semiconductor, defense, and AI software layers rather than directly through IonQ and Rigetti. The Tesla weighting means the fund’s performance will often have little to do with news about quantum.
BOTZ is the structural holding, as it offers exposure to the compute and automation infrastructure that benefits regardless of which qubit modality wins, positioning that may age well if the commercial timeline stretches past current expectations, though it will not match the return profile of QTUM during a quantum melt-up. Investors who want all three angles can blend the funds, weighting toward QTUM for thematic intensity and toward BOTZ for diversification across the broader compute transition.
